Atezolizumab with or Without Bevacizumab and Platinum-Pemetrexed in Patients with Stage IIIB/IV Non-Squamous Non-Small Cell Lung Cancer with EGFR Mutation, ALK Rearrangement or ROS1 Fusion Progressing after Targeted Therapies: A Multicentre Phase II Open-Label Non-Randomised Study GFPC 06-2018